Metronomic per oral decitabine-cedazuridine plus venetoclax in acute myeloid leukemia

To the EditorAcute myeloid leukemia (AML) is a biologically heterogeneous and clinically aggressive hematologic malignancy, with a median age at diagnosis of approximately 70 years [1–3]. Increasin...